Most Marijuana Consumers Don't Believe Trump Administration Will Complete Rescheduling This Year, Poll Shows

Marijuana rescheduling is currently the subject of both D.C. Circuit court challenges and active hearings led by the DEA. While the DOJ has stated that cannabis prohibition interests do not align with the American public, a recent poll indicates that a majority of consumers remain doubtful that the Trump administration will finalize the rescheduling process within this calendar year.

Coverage from Cannabis Business Times, The Globe and Mail, The Hill, Reuters, and Marijuana Moment highlights internal friction, noting that a DEA scientist has testified against the agency's current rescheduling stance. Reports emphasize that while hearings are underway, many stakeholders argue that rescheduling alone may not fully address existing federal policy concerns. Observers are watching the outcome of the D.C.

Circuit challenge and the conclusion of the DEA hearings to determine the next steps for federal cannabis status. The extent to which these legal and administrative actions will influence final policy remains to be determined by the facts currently available.